Indigo Diabetes ^Investors

Indigo Diabetes is a medtech company that aims to revolutionize the management of chronic diseases, with a focus on diabetes. They are developing the worlds first continuous multi-metabolite monitoring (CMM) system for people living with chronic conditions. Their integrated sensor, based on proven silicon photonics technologies, allows for the miniaturization of spectroscopic analysis techniques into a small implantable device. With chronic diseases predicted to rise at a growth rate of 100% by 2050, Indigo Diabetes aims to address the unmet medical needs of those affected, providing a solution that can continuously measure metabolites in the body and improve the quality of life for patients.